ZEISS industry-leading GeminiSEM 500 imaging system to enhance the MACES open access microscopy imaging facility
ZEISS announces that it is providing its GeminiSEM 500, customized for nanomaterial characterization, to the University of California Merced’s Merced Nanomaterials Center for Energy and Sensing (MACES). The University’s recent purchase will support the university’s strong nanomaterial-based research programs and aid in the Center’s research in functional nanomaterials for energy and sensing for NASA missions...
Fast Lyophilisation on the Genevac Series 3 HT Evaporator was developed to provide a rapid, high-throughput alternative to freeze drying HPLC purification fractions.
Traditional evaporation methods of removing solvents, such as water and acetonitrile, often results in formation of a gum or oil due to solvent interactions with the dissolved sample. Employing a Series 3 HT Evaporator with LyoSpeed™ Fast Lyophilisation technology is enabling pharma labs to now routinely dry HPLC fraction samples to a powder form, such that the samples can then be accurately weighed, easily sub-sampled and redissolved. While standard evaporation works...
With the World Health Organisation recently declaring the Zika virus the latest international public health emergency, pressure is growing on pharmaceutical manufacturers to rapidly increase production in order to meet spikes in demand.
Leading global asset management specialist, EquipNet Inc., has witnessed an increase in the number of pharma businesses purchasing pre-owned assets from other top-tier manufacturers to upscale production, as they realise the substantial time and cost savings that can be made. Ben Potenza, Vice President of Marketing at EquipNet, comments, “Pre-owned equipment is generally available immediately and delivery can be...
Discovery Park’s reputation as a centre for science innovation is set to grow even further in the months ahead thanks to a new investment fund located at the Sandwich site.
NCL Innovation, the UK’s leading early stage technology investor, has set up the Discovery Park Technology Investment Fund, which will help cutting edge science and technology firms to get their products or treatments to market. The new fund is managed by NCL and supported by Kent County Council and the Regional Growth Fund with the companies supported by the scheme given the investment and backing they...
AMSBIO announces an extensive range of primary human cancer cells obtained directly from a variety tumor types, including breast, colon and prostate.
Despite significant advances in cancer research and treatments, the eradication of the disease remains elusive. This has led to a more urgent focus on precision medicine and advanced treatments like immunotherapy and the use of oncolytic viruses. Donor derived primary tumor cells offer a more in vivo like model potentially enhancing the development of targeted personalized therapeutics. It is known that using immortalized...
Horizon Discovery Group plc (LSE: HZD), the leading international gene editing company, today announced the introduction of microinjection-ready Cas9 Accelerate Ribonucleoprotein (RNP).
The new Cas9 Accelerate RNP adds to Horizon’s existing collection of microinjection ready reagents for gene editing of animal models. Cas9 Accelerate RNP maximizes gene editing efficiency by enabling CRISPR reagents to sidestep the transcription and translation steps that traditional Cas9 plasmid and mRNA formats must complete before being activated, thereby maximizing gene editing efficiency and lowering the risk of...
Porvair Sciences has announced it has chosen the ELRIG Symposium in Rennes, France (3-4th May 2016) to demonstrate its latest products that enable Lab Automation facilities to optimise sample preparation and improve productivity.
Visitors to the ELRIG Symposium will be able to see the Ultravap Mistral - a product designed to remove the traditional laboratory ‘bottleneck’ of solvent evaporation from microplates. Designed to be automation-friendly, the Ultravap Mistral gives significant throughput advantages to laboratories looking to optimise microplate sample preparation. Faster than centrifugal evaporation for single plates, significant increases in sample throughput are...
PhoreMost Ltd (PhoreMost), a biopharmaceutical company focused on increasing the diversity and affordability of novel therapeutics, announced today that it has entered into an alliance with The Wistar Institute to identify and de-orphan novel targets in cancer, aging and the immune system.
The majority of disease driving targets are currently considered ‘undruggable’, because at first glance they appear structurally resistant to chemical intervention, especially when viewed outside of a cell in a static crystalized form. PhoreMost has developed SITESEEKER®, a new ‘phenotypic’ screening platform that exploits the dynamics of a live-cell environment to uncover hidden druggable target sites across the...
Clinical researchers can now detect copy-neutral factors alongside powerful CNV detection with the addition of SNP probes to the popular CytoSure™ Constitutional v3 array content
Oxford Gene Technology (OGT), The Molecular Genetics Company, has announced the launch of its new CytoSure Constitutional v3 +LOH array for comprehensive genetic analysis of developmental delay disorders. Alongside the latest content for exon-level copy number variation (CNV) coverage, research-validated single nucleotide polymorphism (SNP) probes facilitate detection of loss of heterozygosity (LOH), enabling insightful and...
The Edinburgh Instruments applications team and Dr Gianluca Accorsi, a Research Fellow at CNR Nanotec in Lecce, Italy, worked on the photo-physical properties of Egyptian blue pigment using our Fluorescence Spectrometers.
The interest in non-invasive investigations for the study and identification of painting materials has greatly increased during the past two decades. The nature of museum objects is such that sampling is always kept to a minimum, thus, a spectroscopic approach is ideal for this purpose. An ancient pigment, cuprorivaite, CaCuSi4O10 or otherwise called Egyptian blue, has been photo-physically investigated. The investigation includes qualitative information...
Lonza has launched PowerCHO Advance™ Media, the latest addition to the company’s range of specialized, chemically defined, serum-free media for culturing Chinese Hamster Ovary (CHO) cells.
The new PowerCHO Advance™ Media line offers easy filterability, improved cell-growth promotion and high protein titers. In addition to being hydrolysate-free, serum-free and of non-animal origin, the PowerCHO Advance™ Media offerings are now further enhanced to better support high-density CHO cells in suspension. For therapeutic bioprocessing applications, this medium also facilitates both downstream purification and...
The new All-Party Parliamentary Group (APPG) on Personalised Medicine held its official launch event in the House of Commons today with Life Sciences Minister George Freeman.
The Group aims to help the NHS and patients make best use of the increasing availability of cutting-edge technologies to provide more personalised health and care. The PHG Foundation, an independent health policy think tank that aims to make science work for health, provides the Secretariat for the new Group, supported by partners the Northern Health Science Alliance (NHSA), the Wellcome Trust Sanger Institute and...
BioTek Instruments is proud to announce that President and CEO Briar Alpert was named to the Board of Trustees at the University of Vermont (UVM) as of March 1, 2016.
As part of this six-year term, Mr. Alpert will advise and support UVM management on policy, budgets, strategic planning and other matters to ensure the University’s long-term vision and success. Mr. Alpert has far-reaching ties with the University, having earned his MBA and a BS in mechanical engineering from UVM. Additionally, his father and BioTek’s founder, Dr. Norman Alpert, was an internationally recognized expert in...
Fundraise will support commercial expansion and translational product development
Cambridge Epigenetix (CEGX), a pioneer in the development of epigenetic sequencing technologies, today announced the close of a $21 million Series B financing and the appointment of Dr. Geoff Smith as CEO. The round was led by GV (formerly Google Ventures), with significant participation from Sequoia Capital. Current investors New Science Ventures, Syncona Partners and Cambridge University also joined the round...
Atlas Genetics Ltd, the ultra- rapid Point-Of-Care (POC) molecular diagnostics company, today announces that it has been awarded an SBRI grant from Innovate UK to assist in the development of an ultra-rapid POC multiplex STI test measuring the four most commonly occurring pathogens (Chlamydia trachomatis, Neisseria gonorrhoea, Trichomonas vaginalis and Mycoplasma genitalium) in less than 30 minutes.
Atlas Genetics will develop an ultra-rapid POC stratified medicine diagnostic for patients presenting to Sexual Health Clinics with urethritis, which will allow immediate and accurate selection of appropriate and effective antibiotic treatment. Atlas will be collaborating with the Applied Diagnostic Research and Evaluation Unit at St George’s, University of London and Aquarius Population Health. Key elements of this project include...
Thermo Scientific GENESYS 30 simplifies instrument operation and data interpretation
A new rugged, accurate visible-range spectrophotometer is designed for lab managers and instructors looking for ease of operation and superior photometric performance in a single instrument. The Thermo Scientific GENESYS 30 visible-range spectrophotometer builds on the previous generation of GENESYS with improvements to the user experience in operation and use.
If you are still using film, you should consider some benefits of digital imaging for your gels and blots
The choice between digital imaging and using film for gel and blot documentation is generally based on what the lab has done historically and the availability of equipment and reagents within the lab. Depending on the scenario, the use of film for protein and DNA detection is still popular as it has been the gold standard for decades. However, if you are still using film, you should consider some benefits of digital imaging.
Postnova Analytics, the leading international supplier of Field-Flow Fractionation (FFF) systems, has opened a dedicated office to enhance local support for its growing base of UK customers.
The new company, Postnova Analytics UK Ltd., is based in Herefordshire, and headed up by Paul Clarke - an industry professional with over 30 years experience in separation sciences. In addition to expediting service and support for existing systems, the new Postnova Analytics UK office has invested in a well-equipped laboratory for demonstrations and applications development in the separation of particles, polymers...
Integrated DNA Technologies (IDT), the global leader in nucleic acid synthesis, announces its 2016 Platinum Level sponsorship of the International Genetically Engineered Machine (iGEM) competition.
The iGEM Foundation conducts a yearly international competition for students interested in synthetic biology. Last year, more than 280 teams from 39 countries participated in the competition. IDT also will provide each registered team with up to 20KB of its market leading gBlocks® Gene Fragments synthetic DNA products—for a total value of almost US$1M. “We are very proud to continue our support of iGEM teams that enable...
Universities of Dundee (Scotland), & Cape Town (South Africa) partnering with Bayer (Germany)
World-leading medicinal chemistry and biology at the Universities of Dundee (Scotland) and Cape Town (South Africa) have been allied to the industrial expertise of the Pharmaceuticals Division of Bayer (Germany), one of the world’s leading pharma companies, in an effort to develop critically needed new treatments for tuberculosis (TB). The collaboration combines some of the world’s best knowledge on TB biology, drug...
Chromatrap announces that its high quality ChIP-validated antibodies can now be supplied with optimised matching primer sets.
Using this out-of-box solution there is now no need to waste your valuable time searching databases and designing your own forward and reverse primers. Purchasing Chromatrap ChIP-validated antibodies with their matching high-quality primers, saves you time and gives you the confidence of using primers tested with the exact antibody and gene target with which you work. Many common epigenetic targets of interest...
Merck, a leading science and technology company, reported record results for 2015, emerging stronger from the transformation process that started in 2007. Net sales and EBITDA pre exceptionals were higher than ever before in Merck’s history of nearly 350 years.
“2015 was not only an eventful, but above all a very successful year for Merck. We again achieved profitable growth. By acquiring Sigma-Aldrich, we successfully completed the portfolio realignment of recent years. In immuno-oncology, we initiated six pivotal clinical trials. Research advances and future-oriented investments form the foundation for future success. And our new bold and vibrant branding shows what makes Merck unique,” said Karl-Ludwig Kley, Chairman of the Executive Board....
ZEISS announces that it is providing its GeminiSEM 500, customized for nanomaterial characterization, to the University of California Merced’s Merced Nanomaterials Center for Energy and Sensing (MACES). The University’s recent purchase will support the university’s strong nanomaterial-based research programs and aid in the Center’s research in functional nanomaterials for energy and sensing for NASA missions...
Traditional evaporation methods of removing solvents, such as water and acetonitrile, often results in formation of a gum or oil due to solvent interactions with the dissolved sample. Employing a Series 3 HT Evaporator with LyoSpeed™ Fast Lyophilisation technology is enabling pharma labs to now routinely dry HPLC fraction samples to a powder form, such that the samples can then be accurately weighed, easily sub-sampled and redissolved. While standard evaporation works...
Leading global asset management specialist, EquipNet Inc., has witnessed an increase in the number of pharma businesses purchasing pre-owned assets from other top-tier manufacturers to upscale production, as they realise the substantial time and cost savings that can be made. Ben Potenza, Vice President of Marketing at EquipNet, comments, “Pre-owned equipment is generally available immediately and delivery can be...
NCL Innovation, the UK’s leading early stage technology investor, has set up the Discovery Park Technology Investment Fund, which will help cutting edge science and technology firms to get their products or treatments to market. The new fund is managed by NCL and supported by Kent County Council and the Regional Growth Fund with the companies supported by the scheme given the investment and backing they...
Despite significant advances in cancer research and treatments, the eradication of the disease remains elusive. This has led to a more urgent focus on precision medicine and advanced treatments like immunotherapy and the use of oncolytic viruses. Donor derived primary tumor cells offer a more in vivo like model potentially enhancing the development of targeted personalized therapeutics. It is known that using immortalized...
The new Cas9 Accelerate RNP adds to Horizon’s existing collection of microinjection ready reagents for gene editing of animal models. Cas9 Accelerate RNP maximizes gene editing efficiency by enabling CRISPR reagents to sidestep the transcription and translation steps that traditional Cas9 plasmid and mRNA formats must complete before being activated, thereby maximizing gene editing efficiency and lowering the risk of...
Visitors to the ELRIG Symposium will be able to see the Ultravap Mistral - a product designed to remove the traditional laboratory ‘bottleneck’ of solvent evaporation from microplates. Designed to be automation-friendly, the Ultravap Mistral gives significant throughput advantages to laboratories looking to optimise microplate sample preparation. Faster than centrifugal evaporation for single plates, significant increases in sample throughput are...
The majority of disease driving targets are currently considered ‘undruggable’, because at first glance they appear structurally resistant to chemical intervention, especially when viewed outside of a cell in a static crystalized form. PhoreMost has developed SITESEEKER®, a new ‘phenotypic’ screening platform that exploits the dynamics of a live-cell environment to uncover hidden druggable target sites across the...
Oxford Gene Technology
The interest in non-invasive investigations for the study and identification of painting materials has greatly increased during the past two decades. The nature of museum objects is such that sampling is always kept to a minimum, thus, a spectroscopic approach is ideal for this purpose. An ancient pigment, cuprorivaite, CaCuSi4O10 or otherwise called Egyptian blue, has been photo-physically investigated. The investigation includes qualitative information...
The new PowerCHO Advance™ Media line offers easy filterability, improved cell-growth promotion and high protein titers. In addition to being hydrolysate-free, serum-free and of non-animal origin, the PowerCHO Advance™ Media offerings are now further enhanced to better support high-density CHO cells in suspension. For therapeutic bioprocessing applications, this medium also facilitates both downstream purification and...
The Group aims to help the NHS and patients make best use of the increasing availability of cutting-edge technologies to provide more personalised health and care. 
As part of this six-year term, Mr. Alpert will advise and support UVM management on policy, budgets, strategic planning and other matters to ensure the University’s long-term vision and success. Mr. Alpert has far-reaching ties with the University, having earned his MBA and a BS in mechanical engineering from UVM. Additionally, his father and BioTek’s founder, Dr. Norman Alpert, was an internationally recognized expert in...
Cambridge Epigenetix (CEGX), a pioneer in the development of epigenetic sequencing technologies, today announced the close of a $21 million Series B financing and the appointment of Dr. Geoff Smith as CEO. The round was led by GV (formerly Google Ventures), with significant participation from Sequoia Capital. Current investors New Science Ventures, Syncona Partners and Cambridge University also joined the round...
Atlas Genetics will develop an ultra-rapid POC stratified medicine diagnostic for patients presenting to Sexual Health Clinics with urethritis, which will allow immediate and accurate selection of appropriate and effective antibiotic treatment. Atlas will be collaborating with the Applied Diagnostic Research and Evaluation Unit at St George’s, University of London and Aquarius Population Health. Key elements of this project include...
A new rugged, accurate visible-range spectrophotometer is designed for lab managers and instructors looking for ease of operation and superior photometric performance in a single instrument. The Thermo Scientific GENESYS 30 visible-range spectrophotometer builds on the previous generation of GENESYS with improvements to the user experience in operation and use.
The choice between digital imaging and using film for gel and blot documentation is generally based on what the lab has done historically and the availability of equipment and reagents within the lab. Depending on the scenario, the use of film for protein and DNA detection is still popular as it has been the gold standard for decades. However, if you are still using film, you should consider some benefits of digital imaging.
The new company, Postnova Analytics UK Ltd., is based in Herefordshire, and headed up by Paul Clarke - an industry professional with over 30 years experience in separation sciences. In addition to expediting service and support for existing systems, the new Postnova Analytics UK office has invested in a well-equipped laboratory for demonstrations and applications development in the separation of particles, polymers...
The iGEM Foundation conducts a yearly international competition for students interested in synthetic biology. Last year, more than 280 teams from 39 countries participated in the competition. IDT also will provide each registered team with up to 20KB of its market leading gBlocks® Gene Fragments synthetic DNA products—for a total value of almost US$1M. “We are very proud to continue our support of iGEM teams that enable...
World-leading medicinal chemistry and biology at the Universities of Dundee (Scotland) and Cape Town (South Africa) have been allied to the industrial expertise of the Pharmaceuticals Division of Bayer (Germany), one of the world’s leading pharma companies, in an effort to develop critically needed new treatments for tuberculosis (TB). The collaboration combines some of the world’s best knowledge on TB biology, drug...
Using this out-of-box solution there is now no need to waste your valuable time searching databases and designing your own forward and reverse primers. Purchasing Chromatrap ChIP-validated antibodies with their matching high-quality primers, saves you time and gives you the confidence of using primers tested with the exact antibody and gene target with which you work. Many common epigenetic targets of interest...
“2015 was not only an eventful, but above all a very successful year for Merck. We again achieved profitable growth. By acquiring Sigma-Aldrich, we successfully completed the portfolio realignment of recent years. In immuno-oncology, we initiated six pivotal clinical trials. Research advances and future-oriented investments form the foundation for future success. And our new bold and vibrant branding shows what makes Merck unique,” said Karl-Ludwig Kley, Chairman of the Executive Board....